Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Long-Term Deferred Tax (2025)

CorMedix's Long-Term Deferred Tax history spans 1 years, with the latest figure at $16.3 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax changed N/A year-over-year to $16.3 million; the TTM value through Dec 2025 reached $16.3 million, changed N/A, while the annual FY2025 figure was $16.3 million, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $16.3 million at CorMedix, down from $52.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $52.5 million in Q3 2025 and bottomed at $16.3 million in Q4 2025.